MedPath

Study to assess the effect of Platelet Rich Plasma in osteoarthritis knee.

Not Applicable
Conditions
Health Condition 1: M170- Bilateral primary osteoarthritis of knee
Registration Number
CTRI/2020/03/023685
Lead Sponsor
VMMC and Safdarjung
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients of either gender (50-75yrs) of age diagnosed with primary OA knee of tibio-femoral joint as defined by ACR clinical criteria.

2.Radiological grade II, III of knee osteoarthritis according to Kellgren-Lawrence classification.

Exclusion Criteria

1.Patients having secondary OA knee and bleeding disorders.

2. Ipsilateral cruciate or collateral ligament injury within past three months. 3.Intra articular treatment with any product or joint lavage.

4. Any arthroscopic procedure within prior six months.

5. Any knee surgery within prior twelve months.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To study the clinical outcome in OA knee following Platelet Rich Plasma injection using Knee injury and Osteoarthritis Outcome Score(KOOS) and Visual Analog Scale(VAS) scoring system.Timepoint: 6 months
Secondary Outcome Measures
NameTimeMethod
To assess the cartilage thickness pre and post PRP injection by ultrasonography.Timepoint: 6 months
© Copyright 2025. All Rights Reserved by MedPath